Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1997-12-23
1999-08-31
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514274, 536 173, 536 174, 544309, 544311, 544316, 544313, 544318, 544319, A61K 31715
Patent
active
059454067
ABSTRACT:
Compounds of formula (I): ##STR1## wherein: R is halogen;
REFERENCES:
patent: 3354160 (1967-11-01), Duchinsky et al.
patent: 4248999 (1981-02-01), Baba et al.
Al-Masoudi et al, Synthesis and reactions of some uracil and 5-halouracil nucleosides of 2-acetamido-2-deoxy-D-glucose. Acta Chem. Scand. 51(9), 958-962, 1997.
Sun et al. Synthesis of N-glucuronides of 5-fluorouracil and their antitumor activities. Chin. Chem. Lett. 5(5), 375-376, 1994.
Chouini-Lalanne et al. Synthesis of glucuronides of fluoropyrimidine drugs: N- and 0-glucuronides of 5-fluorcytosine and 5-fluorouracil. Nucleosides Nucleotides. 12(3-4), 331-350, 1993.
Germane et al. A comparison of the antitumor activity and neurotropic properties of 5-fluorouracil, ftorafur, and 5-fluorouracil-N-glucuronide. Eksp. Klin. Farmakoter. 16, 36-44, 1987.
Kulinkovich et al. Synthesis of 5-fluorouracil nucleosides of D-glucopyanuronic acid. Zh. Obshch. Khim. 53(7), 1649-1651, 1983.
Baba et al., 1978, "5-Fluorouracil O-.beta.-D-Glucuronide As a Newly Synthesized Chemically Modified, Nontoxic Anticancer Drug", Gann 69:283-284.
Biessen et al., 1995, "Synthesis of Cluster Galactosides with High Affinity for the Hepatic Asialoglycoprotein Receptor", J. Med. Chem. 38:1538-1546.
Cheng and Ollapally, 1976, "A Facile Alternative Synthesis of 1-(.beta.-D-Xylopyranosyl) Uracil and its 5-Bromo Derivative", J. Carbohydates, Nucleosides, Nucleotides 3:229-234.
Efange et al., 1985, "Synthesis and Biological Activities of 2-Pyrimidinone Nucleosides. 2. 5-Halo-2-pyrimidinone 2'-Deoxribonucleosides", J. Med. Chem. 28:904-910.
Etzold and Langen, 1965, "Pyrimidine Nucleosides of 2-Deoxy-D-Glucose", Chem. Ber. 98:1988-1997 (and certified English translation thereof).
Herdewijn et al., 1991, "Synthesis of 2'-Deoxy-2'-Fluoro-D-Arabinopyranosyl Nucleosides and Their 3', 4'-Seco Analogues", Nucleosides & Nucleotides 10:1525-1549.
Kaneko et al., 1977, "Synthesis of O-Glycosidic Derivatives of 5-Fluorouracil and Their Antitumour Activities", Nucl. Acids. Res., Spec. Pub. No. 3:s35-s38.
Krebs et al., 1994, "Binding of D-Galactose-Terminated Ligands to Rabbit Asialoglycoprotein Receptor", Carbohydrate Res. 254:257-268.
Lee, 1991, "Ligand Structural Requirements for Recognition and Binding by the Hepatic Asialoglycoprotein Receptor", In: Liver Diseases, Targeted Diagnosis and Therapy Using Specific Receptors and Ligands (Wu & Wu, eds.) pp. 65-85.
Lee, 1992, "Biochemistry of Carbohydrate-Protein Interaction", FASEB J. 6:3193-3200.
Lee and Lee, 1987, Preparation of Cluster Glycosides of N-Acetylgalactosamine that Have Subnanomolar Binding Constants Towards the Mammalian Hepatic Gal/GalNAc-Specific Receptor, Glycoconjugate 317-328.
Ogura et al. 1991, "A Stereo-Controlled Nucleoside Synthesis from Anhydro Sugars", Nucleic Acid Chem. 4:109-112.
Ohya et al., 1991, "Preparation of Albumin Microspheres Grafted Galactose Residues Through Polyethylene-Glycol Spacers, Release Behavior of 5-Fluorouracil From Them, and Their Lectin-Mediated Aggregation", J. Macromol. Sci.- Chem. A28:743-760.
Ozaki et al., 1995, "The Differences in Structural Specificity for Recognition and Binding Between Asialoglycoprotein Receptors of Liver and Macrophages", Glycoconjugate J. 12:268-274.
Perigaud et al., 1992, "Nucleoside Analogues As Chemotherapeutic Agents: A Review", Nucleosides & Nucleotides 11:903-945.
Quelo et al., 1972, "Anomerization and Isomerization of 2'-Deoxyuridine by Means of Derivatives Resulting From Saturation of the 5,6 Double Bond of the Pyrimidic Cycle", C.R. Acad. Sc. Paris 275:1137-1140 (and certified English translation thereof).
Saneyoshi et al., 1978, "Synthetic Nucleosides and Nucleotides. XI. Facile Synthesis and Antitumor Activities of Various 5-Fluoropyrimidine Nucleosides", Chem. Pharm. Bull. 26:2990-2997.
Schwarz et al., 1980, "Preparation, Antibacterial Effects and Enzymatic Degradation of 5-Fluorouracil Nucleosides", Collection Czechoslov. Chem. Commun. 45:3217-3229.
Seymour, 1994, "Soluble Polymers for Lectin-Mediated Drug Targeting", Adv. Drug Delivery Rev. 14:89-111.
Sun et al., 1992, "Synthesis of .beta.-D-Galactopyranosides of 5-Fluorouracil", Youji Huaxue 12:273-277 (and certified English translation thereof).
Van der Sluijs and Meijer, 1991, "Limitations on the Specificity of Targeting Asialoglycoprotein-Drug Conjugates to Hepatocytes", In: Liver Diseases, Targeted Diagnosis and Therapy Using Specific Receptors and Ligands (Wu & Wu, eds.) pp. 235-264.
Vorbruggen and Bennua, 1978, "New Simplified Nucleoside Synthesis", Tetrahedron Letters 15:1339-1342.
Wadhwa and Rice, 1995, "Receptor Mediated Glycotargeting", J. Drug Targeting 3:111-127.
Zhong et al., 1995, "Preparation of Galactosyl-Interferon -.alpha..sub.1 and its Hepatic Targeting Property", Chinese J. Med. Chem. 5:164-168 (and certified English translation thereof).
Henin et al., 1991, "Lipophilic Glycosyl Phosphotriester Derivatives of AZT: Synthesis, NMR Transmembrane Transport Study, and Antiviral Activity", J. Med. Chem. 34: 1830-1837.
Oxford Glycosciences (UK) Ltd.
Page Thurman K.
LandOfFree
Therapeutic compounds with pyrimidine base does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic compounds with pyrimidine base, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic compounds with pyrimidine base will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2426558